Previous studies of patients with septic shock have independently demonstrated alterations in plasma concentrations of B-type natriuretic peptide and plasma free cortisol. Previous data suggest that a reciprocal relationship might exist. However, the relationship between these hormones in patients with septic shock is unclear. We sought to compare paired measurement of both B-type natriuretic peptide and plasma free cortisol in a study of septic shock patients.
Septic shock in adults refers to a state of acute circulatory failure characterised by persistent arterial hypotension unexplained by other causes 1 . Neuroendocrine influences, particularly relating to the hypothalamic-pituitary-adrenocortical (HPA) axis, are believed to contribute.
There are scant data regarding potential interactions between the HPA axis and the peripheral natriuretic peptide system. Laboratory data demonstrate that B-type natriuretic peptide (BNP) opposes steroidogenesis via multiple steps 2 . It has also been demonstrated that stress can be associated with reciprocal changes in the HPA axis (increased cortisol) and the peripheral natriuretic peptide system (reduced N-terminal proBNP [NTproBNP]) 3 . This appears to be in conflict with separate observations that BNP 4 and plasma free cortisol 5 independently correlate with severity of illness in patients with septic shock. No previous study has reported paired measurement of BNP and plasma free cortisol in patients with septic shock.
We sought to compare measurement of both BNP and plasma free cortisol on simultaneously collected blood samples in a study of septic shock patients.
MATERIALS AND METHODS
Approval for this study was granted by the Princess Alexandra Hospital Human Research Ethics Committee (project 2005/213) and informed consent was obtained from either the patient or a legally authorised representative. At the time of ethics approval and collection of samples, free cortisol assay was being developed at our institution 4 and was not available for comparison in previous observations of this cohort 5 .
Patients
Twenty-one consecutive adult patients with septic shock were recruited from the tertiary level, multidisciplinary intensive care unit (ICU). Eligible patients were enrolled within 72 hours of admission to ICU with septic shock or development of septic shock while in ICU. Septic shock was defined as severe sepsis with persistent hypotension (i.e. with a mean arterial pressure <60 mmHg or a reduction in systolic blood pressure >40 mmHg from baseline) despite adequate volume resuscitation in the absence of other causes for hypotension 1 . Exclusion criteria included an age of <18 years, the presence of moderate to severe valvular heart disease and when the patient or legally authorised representative declined participation.
Clinical and outcome data
Clinical data included heart rate, rhythm, arterial blood pressure (systolic blood pressure, diastolic blood pressure, mean arterial pressue) and central venous pressure. ICU fluid balance was recorded for the study day (fluid balance). Vasopressor/ inotropic infusion rates and ICU and hospital length of stay and outcome were recorded. Illness severity was quantified using Acute Physiology and Chronic Health Evaluation (APACHE) III and Sequential Organ Failure Assessment scores.
Biochemical assay
Cortisol and cortisone were measured by high performance liquid chromatography with UV detection using methodology published by our laboratory 4 . Prior to measurement by high performance liquid chromatography with UV detection, samples for plasma free cortisol were prepared by equilibrating 500 µl of sample at 37°C for 15 minutes in Amicon Ultra-4 regenerated cellulose 30,000 molecular weight cut-off centrifugal filter devices (Millipore, Billerica, USA) before centrifugation at 3040 g for 20 minutes at 37°C.
Plasma BNP was measured using Biosite Triage immunoassay (Biosite Diagnostics, San Diego, CA, USA). Troponin T (TnT; Elecsys ® Troponin T, 3rd generation immunoassay; Roche Diagnostics Australia Pty Ltd, Castle Hill, NSW), NTProBNP (Elecsys ® proBNP, Roche Diagnostics Australia Pty Ltd, Castle Hill, NSW) and C-reactive protein (CRP; UniCel ® DxI 800 Access ® Immunoassay System, Beckman Coulter Australia Pty Ltd, Gladesville, NSW) concentrations were also measured. Biochemical assay was performed on coded samples by technicians blinded to clinical data.
Statistics
Analysis was performed by SPSS, version 14.0 for Windows (SPSS Inc., Chicago, IL, USA). Descriptive measures were used to evaluate the distribution of variables. Plasma free cortisol, total cortisol, cortisone, BNP, NTproBNP and TnT concentrations were log-transformed to achieve normality before application of linear regression techniques.
Multiple linear regression analyses were undertaken to determine contributions to plasma free cortisol concentration (log plasma free cortisol). Based upon significant correlations, potential predictor variables included APACHE III score, noradrenaline dose, fluid balance, BNP concentration. A backwards elimination procedure was then used to discard predictor variables with P <0.1 in multiple regression models one by one until a final 'best' model was achieved.
In final analyses, P value <0.05 was regarded as significant.
RESULTS
Twenty-one consecutive septic shock patients were studied. Mean±SD age was 65±17 years. ICU mortality was 19% (n=4) and hospital mortality was 29% (n=6). Primary site of infection was abdominal 
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Anaesthesia and Intensive Care, Vol. 40, No. 1, January 2012 38% (n=8), pulmonary 33% (n=7), neurologic 9.5% (n=2), necrotising fasciitis 9.5% (n=2), catheter related sepsis 5% (n=1), mediastinitis 5% (n=1). Noradrenaline infusions were running at the time of assessment in seventeen patients (81%; mean±SD infusion rate 0.124±0.12 µg/kg/minute). In addition to noradrenaline, one patient was receiving adrenaline and one was receiving dopamine. Mean±SD fluid balance on the day of study was 1780±1848 ml (range 1734 to 5320). Correlations between plasma free cortisol and other study variables are shown in Table 1 . The correlation between plasma free cortisol and BNP is illustrated in Figure 1 .
APACHE III score, noradrenaline dose, fluid balance and BNP concentration were entered into multiple linear regression analyses as potential predictors of plasma free cortisol concentration. Backwards elimination confirmed APACHE III (P=0.001) and noradrenaline dose (P=0.02) as independent predictors of plasma free cortisol concentration. The final model incorporating both variables accounted for 68% of variation in plasma free cortisol (R-square=0.682).
DISCUSSION
The cardinal finding of this study is a positive correlation between plasma free cortisol and BNP in a group of patients with septic shock. This new finding challenges previous in vitro 2 and in vivo 3 data which suggest the existence of a reciprocal relationship between the HPA axis and the peripheral natriuretic peptide system. However, a number of potential explanations exist.
It appears that both plasma free cortisol and BNP concentrations are increased proportionally to severity of illness. Plasma free cortisol has previously been demonstrated to reflect illness severity (APACHE II) in patients with sepsis 6 . In the current study, this is further supported by the observation that APACHE III is an independent predictor of plasma free cortisol. Previous data from this cohort also demonstrate APACHE III as an independent predictor of BNP 5 .
It is also possible that although BNP may directly inhibit the adrenocorticotropic hormone pathway, this might be overridden by a non-adrenocorticotropic hormone pathway such as catecholamine-induced steroidogenesis or via an alternate mediator, such as a cytokine 7 . We observed noradrenaline dose as an independent predictor of plasma free cortisol. This effect might be mediated via a neurotransmitter effect at the adrenal cortex 7 .
Another possibility is that cortisol is associated with increased BNP via water retention 8 . Fluid balance has been demonstrated as an independent predictor of plasma BNP concentration in septic shock 5 .
We observed APACHE III (P=0.001) and noradrenaline dose (P=0.02) as independent predictors of plasma free cortisol. A model incorporating both variables explained 68% of variation in plasma free cortisol (R-square=0.682). This new finding supports severity of illness and noradrenaline dose as significant contributors to plasma free cortisol concentration in patients with septic shock.
Another finding of this study was that although a relationship was observed between plasma free cortisol and BNP, no significant correlation existed with NTproBNP. This is readily explained by differences in plasma half life. Although BNP and NTproBNP are synthesised in a 1:1 ratio, their plasma half lives (22 minutes and ~120 minutes respectively) and therefore their plasma concentrations are different 9 .
The hypotheses generated by this single centre cohort study justify further evaluation and confirmation in a broader, preferably multicentre, population of septic patients. Also, mechanistic studies should be performed to help elucidate causality for the potential contributors to plasma free cortisol concentration, such as severity of illness, catecholamine (endogenous and exogenous) and fluid balance. 
